Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults

doi:10.3748/wjg.v26.i41.6488

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 41

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7883)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-5) series.

Item

Count

PDF

560

WORD

193

HTML

4500

Figures (1-10)

199

Tables (1-5)

250

Sum=5702

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

609

Download

1572

Sum=2181

Nov 7, 2020 (publication date) through Aug 25, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Nov 7, 2020; 26(41): 6488-6509
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6488

Table 3 Standardized mean difference with 95% confidence interval of irritable bowel syndrome symptom severity scale

CBT
0.24 (-0.09, 0.57)^a	RPs
1.29 (0.43, 2.16)^a	1.05 (0.13, 1.97)	Acupuncture
2.09 (1.46, 2.73)^a	1.85 (1.13, 2.57)^a	0.80 (0.22, 1.38)	Probiotics
2.39 (1.71, 3.07)^a	2.15 (1.39, 2.90)^a	1.10 (0.48, 1.72)	0.30 (0.07, 0.52)^a	Placebo

^aP < 0.05. CBT: Cognitive behavioral therapy; RPs: Routine pharmacotherapies.

Citation: Dai YK, Wu YB, Li RL, Chen WJ, Tang CZ, Lu LM, Hu L. Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults. World J Gastroenterol 2020; 26(41): 6488-6509
URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6488.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i41.6488